The largest community of pharma leaders

Natalie Yeadon

Natalie Yeadon is the Co-Owner and Managing Director for Impetus Digital. Her company specializes in virtual advisory boards and working committees, and enrols physicians, allied healthcare providers, payers, and patients in a series of online touchpoint activities over a course of time through their online platform. Among many other applications, these online touchpoints can be used to solicit feedback on clinical trial development and endpoints, clinical data implications, launch planning, health economic and market access strategies, and patient support programs, as well as help clients gain insights on how to navigate through complex value frameworks and their varying protocols. Visit https://www.impetusdigital.com to learn more.
23 articles

Digital Technology for Diagnosing and Treating Cancer

Early screening, diagnosis, and management of cancer improve patient survival and reduce symptoms. However, while some common cancers such as breast, prostate, and cervical...

Pharma Going Digital – Is Digital Health the Future?

Digital Health: An Imperative Tool for Pharma The role of digital tools, such as mobile devices/apps, wearables, virtual assistants, and artificial intelligence (AI), in healthcare...

Real-world Data, Drug Access, and Digital

What are “Real-world Data”? “Real-world data” (RWD) refer to data collected in a real-life setting within a heterogeneous population. That is, not in a randomized...